GPRC5A and ovarian cancer: Dysregulation of GPRC5A expression has been observed in other human cancers, such as breast cancer [10], colorectal cancer [11], gastric cancer [12], hepatocellular carcinoma [13], pancreatic cancer [14], prostate cancer [15] and ovarian cancer [16].